Rüther, Eckart

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

Initiative, T. A. D. N., Hollingworth, P., CHARGE consortium, EADI1 consortium, Harold, D., Sims, R., Gerrish, A., Lambert, J.-C., Carrasquillo, M. M., Abraham, R., et al. (2011) · Nature Genetics

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 1,997

Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia: A Meta-analysis

Jansen, W. J., Ossenkoppele, R., Knol, D. L., Tijms, B. M., Scheltens, P., Verhey, F. R. J., Visser, P. J., Aalten, P., Aarsland, D., Alcolea, D., et al. (2015) · JAMA

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 1,610

Anhedonia and motivational deficits in rats: Impact of chronic social stress

Rygula, R., Abumaria, N., Flügge, G., Fuchs, E., Rüther, E., & Havemann-Reinecke, U. (2005) · Behavioural Brain Research

Stress Responses and CortisolNeurotransmitter Receptor Influence on Behavior

Cited by 554

Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage

Vos, S. J. B., Verhey, F., Frölich, L., Kornhuber, J., Wiltfang, J., Maier, W., Peters, O., Rüther, E., Nobili, F., Morbelli, S., et al. (2015) · Brain

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 383

Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum

Jansen, W. J., Janssen, O., Tijms, B. M., Vos, S. J. B., Ossenkoppele, R., Visser, P. J., Amyloid Biomarker Study Group, Aarsland, D., Alcolea, D., Altomare, D., et al. (2022) · JAMA Neurology

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 290

Age-associated changes in the densities of presynaptic monoamine transporters in different regions of the rat brain from early juvenile life to late adulthood

Moll, G. H., Mehnert, C., Wicker, M., Bock, N., Rothenberger, A., Rüther, E., & Huether, G. (2000) · Developmental Brain Research

Neurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research

Cited by 204

Meta-analysis of randomized controlled comparisons of psychopharmacological and psychological treatments for anxiety disorders

Bandelow, B., Seidler-Brandler, U., Becker, A., Wedekind, D., & Rüther, E. (2007) · The World Journal of Biological Psychiatry

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychotherapy Techniques and Applications

Cited by 166

Early Methylphenidate Administration to Young Rats Causes a Persistent Reduction in the Density of Striatal Dopamine Transporters

Moll, G. H., Hause, S., Rüther, E., Rothenberger, A., & Huether, G. (2001) · Journal of Child and Adolescent Psychopharmacology

Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on Behavior

Cited by 147

Trimipramine in Primary Insomnia: Results of a Polysomnographic Double-Blind Controlled Study

Riemann, D., Voderholzer, U., Cohrs, S., Rodenbeck, A., Hajak, G., Rüther, E., Wiegand, M. H., Laakmann, G., Baghai, T., Fischer, W., et al. (2002) · Pharmacopsychiatry

Sleep and related disordersObstructive Sleep Apnea Research

Cited by 145

The atypical antipsychotics olanzapine and quetiapine, but not haloperidol, reduce ACTH and cortisol secretion in healthy subjects

Cohrs, S., Röher, C., Jordan, W., Meier, A., Huether, G., Wuttke, W., Rüther, E., & Rodenbeck, A. (2006) · Psychopharmacology

Stress Responses and CortisolSchizophrenia research and treatment

Cited by 141

Cerebrospinal Fluid Biomarkers and Clinical Progression in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment

Wolfsgruber, S., Polcher, A., Koppara, A., Kleineidam, L., Frölich, L., Peters, O., Hüll, M., Rüther, E., Wiltfang, J., Maier, W., et al. (2017) · Journal of Alzheimer's Disease

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 114

Pharmacological validation of a chronic social stress model of depression in rats: effects of reboxetine, haloperidol and diazepam

Rygula, R., Abumaria, N., Havemann-Reinecke, U., Rüther, E., Hiemke, C., Zernig, G., Fuchs, E., & Flügge, G. (2008) · Behavioural Pharmacology

Treatment of Major DepressionStress Responses and Cortisol

Cited by 109

Citalopram counteracts depressive-like symptoms evoked by chronic social stress in rats

Rygula, R., Abumaria, N., Flügge, G., Hiemke, C., Fuchs, E., Rüther, E., & Havemann-Reinecke, U. (2006) · Behavioural Pharmacology

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 104

Genome-wide significant risk factors for Alzheimer’s disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment

Lacour, A., Espinosa, A., Louwersheimer, E., Heilmann, S., Hernández, I., Wolfsgruber, S., Fernández, V, Wagner, H., Rosende-Roca, M., Mauleón, A., et al. (2017) · Molecular Psychiatry

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 101

Blood Dyscrasias Induced by Psychotropic Drugs

Stübner, S., Grohmann, R., Engel, R. R., Bandelow, B., Ludwig, W.-D., Wagner, G., Müller-Oerlinghausen, B., Möller, H. ‐., Hippius, H., & Rüther, E. (2004) · Pharmacopsychiatry

Pharmacovigilance and Adverse Drug ReactionsSchizophrenia research and treatment

Cited by 100

Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease

Mattsson, N., Groot, C., Jansen, W. J., Landau, S. M., Villemagne, V. L., Engelborghs, S., Mintun, M. M., Lleo, A., Molinuevo, J. L., Jagust, W. J., et al. (2018) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 88

PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment

(ADNI), A. D. N. I., Kleineidam, L., Chouraki, V., Próchnicki, T., van der Lee, S. J., Madrid-Márquez, L., Wagner-Thelen, H., Karaca, I., Weinhold, L., Wolfsgruber, S., et al. (2020) · Acta Neuropathologica

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 62

Nocturnal Melatonin Secretion and Sleep after Doxepin Administration in Chronic Primary Insomnia

Hajak, G., Rodenbeck, A., Adler, L., Huether, G., Bandelow, B., Herrendorf, G., Staedt, J., & Rüther, E. (1996) · Pharmacopsychiatry

Sleep and related disordersCircadian rhythm and melatonin

Cited by 62

Genome-wide association study of vascular dementia

Schrijvers, E. M. C., Schürmann, B., Koudstaal, P. J., van den Bussche, H., Van Duijn, C. M., Hentschel, F., Heun, R., Hofman, A., Jessen, F., Kölsch, H., et al. (2012) · Stroke

Dementia and Cognitive Impairment ResearchGenetic Associations and Epidemiology

Cited by 61

Treatment-Resistant Panic Disorder

Bandelow, B., & Rüther, E. (2004) · CNS Spectrums

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychological Treatments and Disorders

Cited by 57

Prostaglandin D Synthase (β-trace) in Healthy Human Sleep

Jordan, W., Tumani, H., Cohrs, S., Eggert, S., Rodenbeck, A., Brunner, E., Rüther, E., & Hajak, G. (2004) · Sleep

Circadian rhythm and melatoninSleep and Wakefulness Research

Cited by 56

The Use of the Panic and Agoraphobia Scale (P & A) in a controlled clinical trial1

Bandelow, B., Broocks, A., Pekrun, G., George, A., Meyer, T., Pralle, L., Bartmann, U., Hillmer-Vogel, U., & Rüther, E. (2000) · Pharmacopsychiatry

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesCardiac Health and Mental Health

Cited by 53

SUCLG2 identified as both a determinator of CSF Aβ1–42 levels and an attenuator of cognitive decline in Alzheimer's disease

Ramirez, A., van der Flier, W. M., Herold, C., Ramonet, D., Heilmann, S., Lewczuk, P., Popp, J., Lacour, A., Drichel, D., Louwersheimer, E., et al. (2014) · Human Molecular Genetics

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 49

Matrix metalloproteinase 10 is linked to the risk of progression to dementia of the Alzheimer’s type

Martino Adami, P. V., Orellana, A., García, P., Kleineidam, L., Alarcón-Martín, E., Montrreal, L., Aguilera, N., Espinosa, A., Abdelnour, C., Rosende-Roca, M., et al. (2022) · Brain

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 46